Patent Assignment
Reel/Frame 037567/0907
Change of Assignee Address
Recorded: 2016-01-21
Pages: 4
Assignor
ASTEX PHARMACEUTICALS, INC.
Executed: 2016-01-21
Assignee
ASTEX PHARMACEUTICALS, INC.
4420 ROSEWOOD DRIVE, SUITE 200, PLEASANTON, CALIFORNIA, 94588
Covered Properties
(4)
Restoring Cancer Suppressing Functions to Neoplastic Cells Through Dna Hypomethylation
Kit for Delivering Decitabine in Vivo
Method of Administering Decitabine
Methods for Treating Hematological Disorders Through Inhibition of Dna Methylation and Histone Deacetylase
Related Assignments
(7)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jun 22, 2001
From: RUBINFELD, JOSEPH; CHANG, LUCY; DIMARTINO, JORGE
To: SUPERGEN, INC.
Reel/Frame 011948/0565 →
Assignment of Assignor's Interest
Jul 13, 2004
From: JOSHI-HANGAL, RAJASHREE; ZHANG, XICHEN; GONG, STEPHANIE; REDKAR, SANJEEV
To: SUPERGEN, INC.
Reel/Frame 015574/0791 →
Assignment of Assignor's Interest
Jul 13, 2004
From: JOSHI-HANGAL, RAJASHREE; ZHANG, XICHEN; GONG, STEPHANIE; REDKAR, SANJEEV
To: SUPERGEN, INC.
Reel/Frame 015579/0768 →
Assignment of Assignor's Interest
Mar 15, 2005
From: DIMARTINO, JORGE
To: SUPERGEN, INC.
Reel/Frame 016394/0623 →
Change of Name
May 22, 2014
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 032946/0110 →
Change of Name
Jun 16, 2014
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 033108/0181 →
Corrective Assignment to Correct the Receiving Party Data Previously Recorded on Reel 032946 Frame 0110. Assignor(S) Hereby Confirms the Correct Address for Receiving Party.
Jul 3, 2014
From: SUPERGEN, INC.
To: ASTEX PHARMACEUTICALS, INC.
Reel/Frame 033276/0328 →